Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

mark_greener_21

Mark Greener appointed editorial director at Rock Medical Communications

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Greener, Rock Medical Communications

Rock medical communications has appointed journalist and medical writer Mark Greener as editorial director.  Mark spent a decade in the …
Appointment

The ABPI’s new leader: communicating pharma’s value

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Stephen Whitehead

When Richard Barker, the ABPI’s director general decided to step down in May this year after six and a half …
Feature

Eliquis fails in head-to-head study against Lovenox

November 14, 2011 Research and Development, Sales and Marketing BMS, Eliquis, Lovenox, Pfizer

Bristol-Myers Squibb and Pfizer have suffered a setback in their attempts to cement Eliquis’ place in the $20 billion market …
News

Genzyme appoints new leaders for multiple sclerosis and rare disease businesses

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genzyme

Genzyme, a Sanofi company, has appointed William Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare …
Appointment

Lundbeck and Otsuka to collaborate in CNS

November 11, 2011 Research and Development, Sales and Marketing Abilify, CNS, Lundbeck, Otsuka

Lundbeck and Otsuka have signed a major collaborative deal to sell and develop up to five CNS drugs, including a …
News

Coulter Partners appoint Graham Dowsett, and Tarquin Bennett-Coles

November 11, 2011 Research and Development, Sales and Marketing Coulter Partners, recruitment

Graham Dowsett, and Tarquin Bennett – Coles have joined Coulter Partners’ senior management team. Coulter Partners is a leading Executive …
Appointment
Roche pic

Roche’s skin cancer drug receives FDA priority review

November 9, 2011 Research and Development, Sales and Marketing Roche, vismodegib

Roche’s skin cancer pill vismodegib will receive a priority review from the FDA which could see it approved within six …
News

Timothy Wright appointed as global head of development at Novartis Pharmaceuticals

November 9, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis has appointed Dr Timothy Wright as the new global head of development of its pharmaceuticals business, effective immediately.  Dr …
Appointment

Edge Medical Communications makes two senior appointments

November 9, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edge Medical, Medical comms

Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …
Appointment
Lilly HQ picture

Amylin to pay up to $1.6 billion to sever ties with Lilly

November 8, 2011 Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …
News

Strategic alliance executives

November 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTPartners, Strategic alliance executives

Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …
Feature

AZ and Targacept’s novel depression drug misses target

November 8, 2011 Research and Development, Sales and Marketing AstraZeneca

AstraZeneca and Targacept’s next generation depression drug has failed to meet its primary endpoint in a late-stage trial. The first …
News

UK pharma downbeat on its future – survey

November 8, 2011 Research and Development ABPI, R&D, VBP, rsa

The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
News

Daniel Grau appointed as president of Heptares

November 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares

Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors.  Mr Grau has been a …
Appointment
Pfizer Sandwich image

Pfizer to retain an extra 300 jobs at Sandwich site

November 8, 2011 Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich

Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026